The extracellular matrix plays a number of important roles, among them providing structural support and information to cellular structures such as blood vessels imbedded within it. As more complex organisms have evolved, the matrix ability to direct signalling towards the vasculature and remodel in response to signalling from the vasculature has assumed progressively greater importance. This review will focus on the molecules of the extracellular matrix, specifically relating to vessel formation and their ability to signal to the surrounding cells to initiate or terminate processes involved in blood vessel formation.
• Introduction
. Thus, ECM genes are over-represented in the vertebrate genome giving ample grist for the evolutionary mill.
Control of blood vessel formation is illustrative of the signalling process between the ECM and cells. Recent work, which will be discussed in the review, demonstrating how the ECM is involved in regulating developmental and well as adult blood vessel vascularization programs will be the focus. The first part of the review will familiarize the reader with the major players in the ECM. In the second part, the focus will be on the signalling aspects of the ECM and what has been discovered concerning how those molecules signal to cells to mediate vascularization.

ECM: composition and structure
Like the cosmos, the tissues of the human body are composed of mostly (extracellular) 
two classes of molecules are produced by the ECM: fibrous proteins and glycosaminoglycans (GAGs). The fibrous proteins are mainly collagen, laminin and elastin. These fibrous proteins, which participate both as a scaffold and in adhesion in matrix structures, are embedded in GAGs. The chemical properties of GAGs enable them to be highly hydrated giving them gelatinous properties or making them what has been termed a 'ground substance'. This substance imparts a physiological function by facilitating resistance of compressive forces while also allowing diffusion of vital nutrients between the blood and tissue. Further discussion of the structure and properties of the fibrous proteins and GAGs in the ECM is continued by molecule below.
A thorough discussion of all the molecules would fill a book; therefore, brief descriptions will be given, which are pertinent to the role ECM in neovascularization, and reviews will be cited for those interested in more detailed information.
Collagen
The collagens are the most abundant proteins in mammals and in the ECM [4] . Primarily [4] . [5, 6] [7, 8] [39, 42] . Comprising 50% of the dry weight of major arteries, elastin is the most prominent ECM protein in arteries [43] . In vessels, elastic lamina alternate with rings of smooth muscle forming a strong, flexible part of the arterial wall [43, 44] .
With 25 different collagen molecules and their ability to assemble with varied combination of ␣ chains, these molecules have been organized into classes based on their macromolecular properties. Fibril forming or fibrillar collagens (Types I, II, III, V and XI) are the most common and account for 90% of body collagen. These types are involved in forming the classical examples of collagen structure for functions in tissues such as bone, skin, tendons and ligaments. Fibril-associated or FACIT collagens (Types IX, XII, XIV, XVI and XIX) are collagens that do not form fibrils. They are found attached to the fibril-forming collagens forming lateral associations. Thus, it is thought that these collagens are involved with the ordering of collagen fibrils among each other and with other matrix molecules. Network-forming collagens (types IV, VII, VIII and X) form net-like or meshwork structures used in creating sheet-like structures such as in the basement membrane (type IV) or in anchoring fibrils (type VII), which link basement membranes to underlying collagen and laminin in the ECM
Nidogen
Nidogens (or entactins) are one of the four key components of basement membranes (the others being laminin, collagen IV and a proteoglycan) [45] . In mammals, there are two nidogens encoded by distinct genes [46] [47] [48] [49] . Nidogen-1's highest affinity binding site has been localized to one of the EGF repeats on the laminin ␥1 chain [50] . Nidogen-2 has been shown to be involved in cell adhesion, which also involves ␣3 ␤1 and ␣6␤1 integrins [51] . [53, 54] [58] ) [59] . Although embedded in the basement membrane, perlecan also associates with the cell surface via interaction with ␣2␤1 integrin, which also binds to fibrillar collagen [60] . 
Glycosaminoglycans
Syndecan
Receptors for ECM molecules Assembly of the vast network of molecules into an ECM is only part of the picture, as cells must have some mechanism of attaching to the matricellular environment. The syndecans and other transmembrane proteoglycans do function as coreceptors and provide some of the anchoring, but the majority of receptors on animal cells for binding ECM components are the integrins (reviewed in ref. [68]). Consisting of two transmembrane heterodimers (␣ and ␤), which are non-covalently associated glycoproteins, integrins have only been found in meta-
zoans [69] . Indeed, worms only contain two ␣ and one ␤ subunits forming the organism's two integrins, while the number in mammals is estimated to be 18 ␣ and 8 ␤ subunits with 24 combinations of protein having been identified [70] [78] . Dystroglycan is a membrane-spanning glycoprotein heterodimer composed of ␣ and ␤ dystroglycan noncovalently associated subunits translated as a propeptide and proteolytically cleaved into two proteins [79] . It was originally isolated from the dystrophin-glycoprotein complex, which is thought to provide structural stability to the sarcolemma, and mutations in this complex have been associated with several muscular dystrophies (reviewed in ref. [80] ). [81, 82] . Dystroglycan has been shown by cDNA cloning and western blotting to be expressed in bovine aortic endothelial cells and this interaction was mediated by laminin-1 [83] . Angiogenesis as a term is frequently referred to as the process of new blood vessel growth. In the field, however, as previously described [84] [85, 86] [84, 87] .
ECM attachment of dystroglycan is mediated through the ␣ subunit O-linked, mucin type carbohydrates to laminin-2, and this interaction has been shown to be dependent on the glycosylation of dystroglycan. Cytoplasmic attachment of the transmembrane ␤ subunit is accomplished through dystrophin, which binds to the actin cytoskeleton
Evaluation of ECM molecules and their modulators in vessel formation
, this term is associated with a specific biological process, which only partially covers the events involved in new blood vessel formation. In this review, neovascularization refers to the general process of blood vessel growth and broadly involves vasculogenesis, arteriogenesis and angiogenesis. Vasculogenesis describes the process of de novo formation or remodelling of preexisting channels by angioblasts (embryonic development) or circulating vascular progenitor cells (adult neovascularization). Although it is the main player in embryonic development, the functional significance of vasculogenesis in ischemia or peripheral circulation has not been established (reviewed in ref. [84]). Arteriogenesis is defined as the process of maturation or remodelling of existing or newly formed arteries
. The matter of whether arteriogenesis occurs via remodelling of pre-existing vessels or by formation of new vessels from progenitor cells is controversial. Lastly, angiogenesis refers to the process of forming new capillaries from post-capillary venules and is mostly driven by tissue hypoxia
As has been previously described and will be futher illustrated below, the ECM plays critical roles in most of the processes of blood vessel formation. The detailed processes involved in de novo and adult blood vessel formation have been extensively reviewed [88] [89] [90] [91] [92] [93] [94] . [97, 98] . Lastly, angiopoietin-1-Tie2 receptor mediates recruitment of smooth muscle-like pericytes to cover capillaries [99] [100] [101] . During angiogenesis, this primary network is remodelled, pruned and specialized into arterial and vein capillary beds [88] . Organ capillary networks, which are formed from inside the organs and are not grown from larger vessels, are then joined to the other forming network to build the circulatory system (reviewed in ref. [93] 
In blood vessel formation of embryonic development, vasculogenesis and angiogenesis participate in the formation of the vasculature. Briefly, in vasculogenesis, hemangioblasts are derived from groups of FGF2-stimulated splanchnic mesoderm cells as precursor cells of blood vessels and blood cells [95]. VEGF-VEGF receptor 2 (Flk1/KDR) signalling mediates the differentiation of hemangioblasts into cell aggregates or blood islands [96]. Outer cells of blood islands differentiate into angioblasts (blood vessel precursors) while the inner cells become hematopoietic stem cells (blood cell precursors). Next, angioblasts become endothelial cells, which form the internal lining of blood vessels and, later, organize into tube structures creating a network of capillaries or the primary capillary plexus. VEGF-VEGF receptor 1 (Flt1) controls the formation of tubes from blood islands
Determination of essential ECM components of vessel formation
Since ECM components are the scaffolding that girds the vascular system, one collection of mutations that would be expected to effect vessel formation would be disruption of the basement membrane structure or attachment of components to the structure resulting in no or malformed configurations. While these phenotypes involving tube formation and [102] [103] [104] [105] [106] ). Also, matrix metalloproteases (MMPs) have been covered in a review in this series [107] and by others [108] [109] [110] [111] .
Fig. 1 Effects on arteriogenesis by synectin disruption in mice. (A) Laser Doppler images of the time course of perfusion in hindlimbs of synectin wildtype (WT) and null (KO) mice (perfusion is indicated by colour where red > yellow > green > blue) (B) Quantitative analysis of laser Doppler images indicates significant alterations in hindlimb reperfusion immediate post and 14 days after femoral artery ligation in synectin null mice (black bars
Collagen-I and laminins are important for vessel structural integrity and provide contrasting signals in angiogenesis As previously described in Collagens, Collagen-I is a member of the fibril forming family of collagens, which make up a large percentage of the ECM in the body and is a constituent of many tissues that undergo embryonic angiogenesis during development [112] . In vivo, a mouse knockout model of type I collagen generated by insertional mutagenesis produced a lethal phenotype between day 12 and day 14 of gestation [113] . While distribution of other collagens, laminin and fibronectin were not effected, no type I collagen was detected in the mutant embryos. The mutants displayed a phenotype of mechanical instability of vessels due to rupture as well as defects in hemopoietic cells of the liver [113] . In vitro, bovine aortic endothelial cells synthesize type I collagen and its production is limited to the cells forming capillary tubes in the endothelial cell monolayer [114, 115] . Also, human umbilical vein endothelial cell monolayers have demonstrated a robust angiogenesis with type I collagen and sulfated GAGs [116, 117] . In the embryo, capillary development has been shown to begin with endothelial precursor cells transitioning to a spindle-shaped morphology, followed by alignment into cord-like structures that form a network [118] [119] [120] [121] (reviewed in ref. [122] ). These cord-like structures undergo maturation, forming lumens for blood transport and the endothelial cells attach to basal lamina [119, 123] . Inhibitors of collagen triple helix formation or fibrillogenesis prevent angiogenesis in the chick embryo [116] [122] . Further support is demonstrated by Src kinases modulating vascular morphogenesis [126] . These kinases have been suggested to be involved in angiogenesis by regulating vascular permeability [127] . Also, Rho family members have been shown to be involved in actin cytoskeletal changes (reviewed in ref. [128] [169] ). It was isolated as a proteolytic fragment from a hemangioendothelioma, cloned and shown to regress primary tumours in mice [170] . Null mice generated by inactivation of the collagen XVIII gene, Col18a1, appeared to have no major defect in vascular patterning or capillary density in most organs, and the experiments involving tumour growth showed no significant difference with wildtype animals [171, 172] . Further examination, however, using a modified aortic explant assay, revealed a two-fold increase in microvessel growth in knockout versus wildtype animals, which could be eliminated by administration of low levels (0.1 g/mL) of endostatin [173] [176] ). Arresten, derived from (␤1(IV)NC1), has been shown to inhibit endothelial cell proliferation and tumour growth [103, 177] . Mechanistically, arresten also mediates its effects via ␣1␤1 integrin, which inhibits migration, proliferation and tube formation in endothelial cells [178] . Similarly, tumstatin, canstatin and an unnamed type IV (␣6) chain have been shown to be inhibitors of angiogenesis [176] . Another recent report links the p53 tumour suppressor pathway to production of collagen XVIII and collagen IV anti-angiogenic fragments, endostatin and tumstatin (reviewed in ref. [179] ) [180] . The enzyme, ␣(II) collagen prolyl-4-hydroxylase (␣2PH), is responsible for the hydroxylation of proline, which is critical for triple-helical strand formation in collagen biosynthesis and is a rate-limiting step in the pathway [181] . p53 transcriptionally activates ␣2PH gene, which results in the extracellular release of collagen fragments, endostatin and tumstatin [180] [182, 183] . Endorepellin, from the C-terminal, domain V fragment of perlecan, has also shown to inhibit angiogenesis and block migration of endothelial cells [184] , which ultimately leads to actin disassembly (reviewed in ref. [12] ) [185] . ␥-elastins are peptides generated by partial hydrolysis of ligamentum nuchae elastin in 1M KOH in 80% aqueous ethanol [186] . The sequence, VGVAPG-found in ␥-elastins, has been found to be one of the angiogeneic motifs that are repeated multiple times in tropoelastin [187] . These [190] ) and will be the focus of discussion. Eight receptors have been identified for TSP1 and, of these, five (CD36 [191, 192] , CD47 [193] , heparan sulfate proteoglycans [194] , ␣3␤1 integrin [195] , and ␣4␤1 integrin [196] ) are thought to be involved in angiogenesis. In addition, TSP1 has also been shown to participate in platelet aggregation [197] . TSP1 [201] . Also, an abnormal bleeding time led to discovery that TSP2 null mice had greater vascular density than wildtype, which correlated with previous in vitro data suggesting that TSP2 was an inhibitor of angiogenesis [201] . Recently, a TSP1-TSP2 double knockout (TSP-DKO) was generated, which has provided some insight into the role of TSP in angiogenesis [202] . Immunostaining [198, 202] .
CCN proteins
The CCN family of secreted proteins were individually discovered and characterized but were later grouped into a protein family based on the high degree of similarity in their predicted secondary structure [203, 204] . These six proteins, the family name of which is derived from the first initials of the first three members (Cysteine-rich protein 61- [205] [206] [207] [208] [209] and a book [204] [211, 214] . CCN1 has also been associated in regulation of expression of other tissues response to injury such as bone fracture repair and liver regeneration [214, 215] [217] . Also, in ␣v integrin null mice, 80% of the mice die due to undervascularization of the placenta. In the placental labyrinth zone, the ␣v integrin null mice appear morphologically similar to CCN1-null mice with foetal vessels at the chorionic plate appearing collapsed or absent [219] . Since embryonic vessels and the primary vascular plexus of the yolk sac successfully form, CCN1 appears not to be required for vasculogenesis [217] .
In [205, 206, 222] .
Not surprisingly, due to their related structure, CCN2 (CTGF, connective tissue growth factor) has similar properties of CCN1. Both proteins play key regulatory roles in survival and function of endothelial cells and in angiogenesis [208] by promoting endothelial cell growth, adhesion and migration [212, [223] [224] [225] . As for their roles in embryonic angiogenesis, CCN2 null mice are also embryonic lethal but not due to placental vascular defects or vessel integrity but because of defects in endochondral ossification resulting in skeletal defects from dysregulation of bone growth [226] of which one result is the inability to breathe at birth due to abnormal rib formation. Closer examination of these mice, however, also reveals that CCN2 null mice have expansion of the hypertrophic zones in growth plates, which has been previously demonstrated to result from an impairment of angiogenesis [226] [227] [228] . Immunostaining for PECAM confirmed that in neonatal CCN2 wildtypes, a fine network of capillaries was present in welldeveloped ossification zones while in CCN2 null mice capillary formation was much less extensive [226] . These defects were ultimately suggested to be due to decreased expression of VEGF in the hypertrophic zones of CCN2-null mice. Reduced CCN2 results in inefficient infiltration of osteoclasts/chondroclasts, which express MMP-9. By these cells not being present, the level of MMP-9 was reduced and MMP-9 is required for growth plate angiogenesis [229] . MMP mediated degradation of the matrix activates VEGF, which is chemotactic for osteoclasts [226, 227] [232] ) [233] . Thus, early analyses of CCN3 were focused in cancer [232] . Later, with the identification of the CCN protein family, CCN3 was characterized as CCN1 and CCN2 and was shown to be involved in cell migration, adhesion and survival in endothelial cells [234] . CCN3 is also involved in the angiogenic process as it induced neovascularization in the rat cornea model [234] as well as being highly expressed in granulation tissue of cutaneous wounds five to seven days after injury [235] , and rat aortic vascular smooth muscle cells express CCN3, in vivo and in vitro with high expression in the aorta, and start with low expression at day 7 but increase to high expression in the intima at day 14 in the rat carotid artery balloon injury model implicating CCN3 in vascular injury [236] . There are some distinct differences between CCN3 and the other CCNs. CCN3 from yeast has been shown to interact with Notch1 and influence Notch signalling through the Notch C-terminus [237] [235] . Further delineation of the role of CCN3 will most likely be provided by production of a CCN3 null mouse.
The remaining family members CCN4, CCN5 and CCN6 (Wnt inducible secreted proteins-1,-2 ,-3,  Wisp -1,-2 ,-3) have had less examination due to a lack of readily available reagents (i.e. recombinant material and antibodies) [206] . CCN5 (also known as COP-1), which is the only CCN family member that lacks the CT module, was found to inhibit proliferation of vascular smooth muscle cells [238] . Human mutations in CCN6 have been reported to be associated with progressive pseudorheumatoid dysplasia [239] 
